Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Krsnaa Diagnostics announced its FY26 audited financial results. The company reported revenue of Rs.772.8 crore and a 31% YoY increase in Profit After Tax to Rs.101.4 crore, achieving its highest ever PAT. The Board also recommended a final dividend of Rs.2 per share.
May 25 2026 23:33:03
Krsnaa Diagnostics Ltd - 543328 - Appointment/Re-Appointment Of Auditors
Krsnaa Diagnostics' Board of Directors met and approved the audited standalone and cons. financial results for Q4 FY26 and the financial year ended March 31, 2026. The Board also recommended a final dividend of Rs.2 per equity share for FY26, subject to shareholder approval.
May 25 2026 21:28:19
Krsnaa Diagnostics Limited
Krsnaa Diagnostics' board recommended a final dividend of Rs. 2 per equity share for the financial year 2025-26. The record date for this dividend is yet to be fixed by the company.
May 25 2026 20:41:31
Krsnaa Diagnostics Ltd - 543328 - Corporate Action-Board approves Dividend
Krsnaa Diagnostics board recommended a final dividend of ₹2.00 per equity share for FY26. This dividend, 40% of the ₹5 face value, requires shareholder approval at the upcoming AGM.
May 25 2026 20:29:47
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Krsnaa Diagnostics has scheduled a post-earnings conference call on May 26, 2026, at 12:30 Hrs. (IST). The management will discuss Q4 & FY26 financial results, followed by an interactive Q&A session.
May 20 2026 20:53:31
Krsnaa Diagnostics Limited
Krsnaa Diagnostics received income tax demand totaling Rs. 11.31 crore for AY 2018-19 and 2019-20 following an Income Tax search. The company has challenged the orders and remains confident in its defense.
May 20 2026 19:39:10
Krsnaa Diagnostics Ltd - 543328 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Krsnaa Diagnostics received income tax assessment orders for AY 2018-19 and 2019-20, resulting in a demand of Rs.11.31 crore. The company is challenging these orders before appellate forums.
May 20 2026 19:35:44
Krsnaa Diagnostics Limited
Krsnaa Diagnostics' Board of Directors will meet on May 25, 2026. The key agendas include the consideration and approval of the audited standalone and consolidated financial results for the financial year ended March 31, 2026, and a recommendation for a final dividend.
May 19 2026 00:17:45
Krsnaa Diagnostics Limited
Krsnaa Diagnostics board will convene on May 25, 2026. The agenda includes reviewing the Q4 FY26 financial results and potentially recommending a dividend for the financial year.
May 19 2026 00:04:43
Krsnaa Diagnostics Ltd - 543328 - Board Meeting Intimation for Quarter And Year Ended March 31, 2026.
Krsnaa Diagnostics announced that its Board of Directors will convene on May 25, 2026. The agenda includes the consideration and approval of audited financial results for Q4 FY26 and the recommendation of a dividend.
May 18 2026 23:58:47
Read More